Differential association of protein tyrosine kinases with the T cell receptor is linked to the induction of anergy and its prevention by B7 family-mediated costimulation

Journal of Experimental Medicine

Volumn 184, Issue 2, 1996, Pages 365-376

  Boussiotis, Vassiliki A ^b   Barber, Dwayne L ^a   Lee, Bohyung J ^c   Gribben, John G ^c   Freeman, Gordon J ^c   Nadler, Lee M ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CELL SURFACE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR;

ARTICLE; CLONAL ANERGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; T LYMPHOCYTE ACTIVATION;

EID: 0029810388     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.2.365     Document Type: Article

References (91)

1. Weiss, A., and D.R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell. 76:263-274.
2. fyn. Cell. 70:751-763.
3. Chan, A.C., B.A. Irving, J.D. Fraser, and A. Weiss. 1991. The ζ chain is associated with a tyrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phosphoprotein. Proc. Natl. Acad. Sci. USA. 88:9166-9170.
4. Chan, S.H., M. Iwashima, C.W. Turck, and A. Weiss. 1992. ZAP-70: A 70kD protein-tyrosine kinase that associates with TCRζ chain. Cell. 71:649-662.
5. Glaichenhaus, N., N. Shastri, D.R. Littman, and J.M. Turner. 1991. Requirement for association of p56lck with CD4 in antigen-specific signal transduction in T cells. Cell. 64:511-520.
6. lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line. Mol. Cell. Biol. 12:4521-4530.
7. Molina, T.J., K. Kishihara, D.P. Siderovski, W. van Ewijk, A. Narendran, E. Timms, A. Wakeham, C.J. Paige, K.U. Hartmann, A. Veillette et al. 1992. Profound block in thymocyte development in mice lacking p56lck. Nature (Lond.). 357:161-164.
8. fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell. 70:741-750.
9. Straus, D., and A. Weiss. 1992. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell. 70:585-593.
10. Mueller, D.L., M.K. Jenkins, and R.H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7: 445-480.
11. Jenkins, M.K., and R.H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302-319.
12. Jenkins, M.K., J.D. Ashwell, and R.H. Schwartz. 1988. Allogeneic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen-presenting cells. J. Immunol. 140:3324-3330.
13. Mueller, D.L., M.K. Jenkins, and R.H. Schwartz. 1989. An accessory cell-derived costimulatory signal acts independently of protein kinase C activation to allow T cell proliferation and prevent the induction of unresponsiveness. J. Immunol. 142:2617-2628.
14. Freeman, G.J., A.S. Freedman, J.M. Segil, G. Lee, J.F. Whitman, and L.M. Nadler. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:2714-2722.
15. Linsley, P.S., W. Brady, L. Grosmaire, A. Aruffo, N.K. Damle, and J.A. Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173: 721-730.
16. Freeman, G.J., J.G. Gribben, V.A. Boussiotis, J.W. Ng, V. Restivo, L. Lombard, G.S. Gray, and L.M. Nadler. 1993. Cloning of B7-2: a CTLA4 counter-receptor that costimulates human T cell proliferation. Science. 262:909-911.
17. Azuma, M., D. Ito, H. Yagita, K. Okumura, J.H. Phillips, L.L. Lanier, and C. Somoza. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature (Lond.). 366:76-79.
18. Harding, F.A., J.G. McArthur, J.A. Gross, D.H. Raulet, and J.P. Allison. 1992. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature (Lond.). 356:607-609.
19. Gimmi, C.D., G.J. Freeman, J.G. Gribben, G. Gray, and L.M. Nadler. 1993. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc. Natl. Acad. Sci. USA. 90:6586-6590.
20. Boussiotis, V.A., G.J. Freeman, G. Gray, J. Gribben, and L.M. Nadler. 1993. B7 but not ICAM-1 costimulation prevents the induction of human alloantigen specific tolerance. J. Exp. Med. 178:1753-1763.
21. Essery, G., M. Feldmann, and J. Lamp. 1988. Interleukin-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes. Immunology. 64:413-117.
22. Tan, P., C. Anasetti, J.A. Hansen, J. Melrose, M. Brunvard, J. Bradshaw, J.A. Ledbetter, and P. Linsley. 1993. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 177:165-173.
23. Boussiotis, V.A., D.L. Barber, T. Nakarai, G.J. Freeman, J.G. Gribben, G.M. Bernstein, A.L. D'Andrea, J. Ritz, and L.M. Nadler. 1994. Prevention of T cell anergy by signaling through the γc chain of the IL-2 receptor. Science (Wash. DC). 266:1039-1042.
24. Boussiotis, V.A., G.J. Freeman, J.D. Griffin, G.S. Gray, J.G. Gribben, and L.M. Nadler. 1994. CD2 is involved in maintenance and reversal of human alloantigen specific clonal anergy. J. Exp. Med. 180:1665-1673.
25. Freeman, G.J., V.A. Boussiotis, A. Anumanthan, G.M. Bernstein, X.-Y. Ke, P.D. Rennert, G.S. Gray, J.G. Gribben, and L.M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity. 2:523-532.
26. Anderson, P., M.L. Blue, C. O'Brien, and S.F. Schlossman. 1989. Monoclonal antibodies reactive with the T cell receptor ζ chain: production and characterization using a new method. J. Immunol. 143:1899-1904.
27. Transy, C., P.E. Moingeon, B.C. Marshall, S. Schlossman, and E.L. Reinherz. 1989. Most anti-human CD3 monoclonal antibodies are directed to the CD3 epsilon subunit. Eur. J. Immunol. 19:947-950.
28. Philips, D.R., and M. Morrison. 1971. Exposed protein of the intact human erythrocyte. Biochemistry. 10:1766-1771.
29. Barber, D., and A. D'Andrea. 1994. Erythropoietin and interleukin-2 activate distinct JAK kinase family members. Mol. Cell. Biol. 14:6506-6514.
30. Rudd, C.E., J.M. Trevillyan, J.D. Dasgupta, L.L. Wong, and S.F. Schlossman. 1988. The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. Proc. Natl. Acad. Sci. USA. 85:5190-5194.
31. c-Fes. J. Mol. Chem. 269:5764-5769.
32. June, C.H., M.C. Fletcher, J.A. Ledbetter, and L.E. Samelson. 1990. Increases in tyrosine phosphorylation are detectable before phospholipase C activation after T cell receptor stimulation. J. Immunol. 144:1591-1599.
33. Klausner, R.D., J.J. O'Shea, H. Luong, P. Ross, J. Bluestone, and L.E. Samelson. 1987. T cell receptor tyrosine phosphorylation. Variable coupling for different activating ligands. J. Biol. Chem. 262:12654-12659.
34. Weissman, A.M., P. Ross, E.T. Luong, P. Garcia-Morales, M.L. Jelachich, W. Biddison, R.D. Klausner, and L.E. Samelson. 1988. Tyrosine phosphorylation of the human T cell antigen reseptor ζ chain: activation via CD3 but not CD2. J. Immunol. 141:3532-3536.
35. Koyasu, S., D.J. McConkey, L.K. Clayton, S. Abraham, B. Yandava, T. Katagiri, P. Moingeon, T. Yamamoto, and E.L. Reinherz. 1992. Phosphorylation of multiple CD3ζ tyrosine residues leads to formation of pp21 in vitro and in vivo. J. Biol. Chem. 267:3375-3381.
36. Baniyash, M., P. Garcia-Morales, E. Luong, L.E. Samelson, and R.D. Klausner. 1988. The T cell antigen receptor ζ chain is tyrosine phosphorylated upon activation. J. Biol. Chem. 263:18225-18230.
37. Quian, D., I. Griswold-Prenner, M. Rich Rosner, and F.W. Fitch. 1993. Multiple components of the T cell antigen receptor complex become tyrosine-phosphorylated upon activation. J. Biol. Chem. 268:4488-4493.
38. Straus, D.B., and A. Weiss. 1993. The CD3 chains of the T cell antigen receptor associate with ZAP-70 tyrosine kinase and are tyrosine phosphorylated after receptor stimulation. J. Exp. Med. 178:1523-1530.
39. Samelson, L.E., M.C. Fletcher, J.A. Ledbetter, and C.H. June. 1990. Activation of tyrosine phosphorylation in human T cells via the CD2 pathway. Regulation by the CD45 tyrosine phosphatase. J. Immunol. 145:2448-2454.
40. Samelson, L.E., A.F. Phillips, E.T. Luong, and R.D. Klausner. 1990. Association of the fyn protein-tyrosine kinase with the T cell antigen receptor. Proc. Natl. Acad. Sci. USA. 87: 4358-4362.
41. lck and ti(TCR)/CD3 complexes. Eur. J. Immunol. 21:1663-1668.
42. Burgess, K.E., M. Yamamoto, K.V.S. Prasad, and C.E. Rudd. 1992. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor ζ chain/CD3 and protein-tyrosine kinases p56lck and p59fyn. Proc. Natl. Acad. Sci. USA. 89:9311-9315.
43. + T lymphocytes by human blood dendritic cells in vitro. J. Clin. Invest. 90:229-237.
44. + T cells. J. Exp. Med. 173:759-762.
45. Guerder, S., J. Meyerhoff, and R. Flavell. 1994. The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity. 1:155-166.
46. Harlan, D.M., H. Hengartner, M.L. Huang, Y.H. Kang, R. Abe, R.W. Moreadith, H. Pircher, G.S. Gray, P.S. Ohashi, G.J. Freeman et al. 1994. Transgenic mice expressing both B7 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T lymphocyte unresponsiveness. Proc. Natl. Acad. Sci. USA. 91:3137-3141.
47. Verwilghen, J., R. Lovis, M. De Boer, P. Linsley, G. Haines, A. Koch, and R. Pope. 1994. Expression of functional B7 and CTLA4 on rheumatoid synovial T cells. J. Immunol. 153: 1378-1385.
48. Chen, L., A. Ashe, W.A. Brady, I. Hellstrom, K.E. Hellstrom, J.A. Ledbetter, C. McGowan, and P. Linsley. 1992. Costimulation of antitumor immunity by the B7 counter-receptor for the T lymphocyte molecule CD28 and CTLA-4. Cell. 71:1093-1102.
49. + T cells by B7-transfected melanoma cells. Science (Wash. DC). 259:368-370.
50. Ramarathian, L., M. Castle, Y. Wu, and Y. Liu. 1994. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment and effector function of antitumor T cells. J. Exp. Med. 179:1205-1214.
51. Matulonis, U., C. Dosiou, C. Lamont, G.J. Freeman, P. Mauch, L.M. Nadler, and J.D. Griffin. 1995. Role of B7-1 in mediating an immune response to myeloid leukemia cells. Blood. 85:2507-2515.
52. Turka, L.A., P.S. Linsley, H. Lin, W. Brady, J.M. Leiden, R.Q. Wei, M.L. Gibson, X.G. Zheng, S. Myrdal, D. Gordon et al. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA. 89:11102-11105.
53. Linsley, P.S., P.M. Wallace, J. Johnson, M.G. Gibson, J.L. Greene, J.A. Ledbetter, C. Singh, and M.A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science (Wash. DC). 257:792-795.
54. Lenschow, D.J., Y. Zeng, J.R. Thistlethwaite, A. Montag, W. Brady, M.G. Gibson, P.S. Linsley, and J.A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science (Wash. DC). 257:789-792.
55. Lin, H., S.F. Bolling, P. Linsley, R.Q. Wei, D. Gordon, C.A. Thompson, and L.A. Turka. 1993. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J. Exp. Med. 178:1801-1806.
56. Blazar, B.R., P.A. Taylor, P.S. Linsley, and P.A. Vallera. 1994. In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice. Blood. 83:3815-3825.
57. Finck, B., P. Linsley, and D. Wofsy. 1994. Treatment of murine lupus with CTLA4Ig. Science (Wash. DC). 265:1225-1227.
58. Milich, D., P. Linsley, J. Hughes, and J. Jones. 1994. Soluble CTLA-4 can suppress autoantibody production and elicit long term responsiveness in a novel transgenic model. J. Immunol. 153:429-435.
59. Tsygankov, A.Y., C. Spana, B.R. Rowley, R.C. Penhallow, A.L. Burkhardt, and J.B. Bolen. 1994. Activation-dependent tyrosine phosphorylation of fyn-associated proteins in T lymphocytes. J. Biol. Chem. 269:7792-7800.
60. Gauen, L.K.T., A.N.T. Kong, L.E. Samelson, and A.S. Shaw. 1992. p59fyn tyrosine kinase associates with multiple T-cell receptor subunits through its unique amino-terminal domain. Mol. Cell. Biol. 12:5438-5446.
61. fyn domains associate with nonphosphorylated and phosphorylated Ig-α. Proc. Natl. Sci. USA. 91:4268-4272.
62. Wange, R.L., S.N. Malek, S. Desiderio, and L.E. Samelson. 1993. Tandem SH2 domains of ZAP-70 bind to T cell antigen receptor ζ and CD3∈ from activated Jurkat T cells. J. Biol. Chem. 268:19797-19801.
63. Iwashima, M., B. Irving, N. van Oers, A. Chan, and A. Weiss. 1994. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science (Wash. DC). 263: 1136-1139.
64. Koyasu, S., A.G. Tse, P. Moingeon, R.E. Hussey, A. Mildonian, J. Hannisian, L.K. Clayton, and E.L. Reinherz. 1994. Delineation of a T-cell activation motif required for binding of protein tyrosine kinases containing tandem SH2 domains. Proc. Natl. Sci. Acad. USA. 91:6693-6697.
65. Hatada, M.H., X. Lu, E.R. Laird, J. Green, J.P. Morgenstern, M. Lou, C.S. Marr, T.B. Phillips, M.K. Ram, K. Theriault et al. 1995. Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor. Nature (Lond.). 377:32-38.
66. Sloan-Lancaster, J., A.S. Shaw, J.B. Rothbard, and P.M. Allen. 1994. Partial T cell signaling: altered phospho-ζ and lack of Zap70 recruitment in APL-induced T cell anergy. Cell. 79:913-922.
67. Madrenas, J., R.L. Wange, J.R. Wange, N. Isakov, L.E. Samelson, and R.N. Germain. 1994. ζ phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science (Wash. DC). 267:515-518.
68. Migita, K., K. Eguchi, Y. Kawabe, T. Tsukada, Y. Ichinose, and S. Nagataki. 1995. Defective TCR-mediated signaling in anergic T cells. J. Immunol. 155:5083-5087.
69. fyn. J. Immunol. 149:2887-2893.
70. Gajewski, T.F., D. Qian, P. Fields, and F.W. Fitch. 1994. Anergic T-lymphocyte clones have altered inositol phosphate, calcium and tyrosine kinase signaling pathways. Proc. Natl. Acad. Sci. USA. 91:38-42.
71. lck in CD4 T cells from HIV-1 infected patients. Int. Immunol. 6:611-621.
72. lck in thymopoiesis. EMBO (Eur. Mol. Biol. Organ.) J. 12:1671-1680.
73. Lancki, D., D. Qian, P. Fields, T. Gajewski, and T.W. Fitch. 1995. Differential requirements for tyrosine kinase fyn in the functional activation of antigen-specific T lymphocytes clones through TCR or Thy-1. J. Immunol. 155:4363-4370.
74. June, C.H., J.A. Ledbetter, M.M. Gillespie, T. Lindsten, and C.B. Thompson. 1987. T-cell proliferation involving the CD28 pathway is associated with cyclosporin-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7:4472-4481.
75. Ward, S.G., J. Westwick, N.D. Hall, and D.M. Sansom. 1993. Ligation of CD28 receptor by B7 induces formation of D-3 phosphoinositides in T lymphocytes independently of T cell receptor/CD3 activation. Eur. J. Immunol. 23:2572-2577.
76. Fraser, J.D., and A. Weiss. 1992. Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28. Mol. Cell. Biol. 12:4357-4363.
77. Fraser, J.D., M.E. Newton, and A. Weiss. 1992. CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation. J. Exp. Med 175:1131-1134.
78. August, A., S. Gibson, K. Kawakami, T. Kawakami, G.B. Mills, and B. Dupont. 1994. CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc. Natl. Acad. Sci. USA. 91:9347-9351.
79. August, A., and B. Dupont. 1994. Activation of src family kinase lck following CD28 crosslinking in the Jurkat leukemic cell line. Biochem. Biophys. Res. 199:1466-1473.
80. Hutchcroft, J.E., and B.E. Bierer. 1994. Activation-dependent phosphorylation of the T-lymphocyte surface receptor CD28 and associated proteins. Proc. Natl. Acad. Sci. USA. 91: 3260-3264.
81. fyn regulate CD28 binding to phosphotidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein tyrosine kinase ITK: implications for T cell costimulation. Proc. Natl. Acad. Sci. USA. 92:8891-8895.
82. Stein, P., J. Fraser, and A. Weiss. 1994. The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of IL-2 secretion and association with phosphatidylinositol 3′-kinase. Mol. Cell. Biol. 14:3392-3402.
83. lck is increased in human T cells activated via CD2. Eur. J. Immunol. 269:1225-1227.
84. Bell, G.M., J.B. Bolen, and J.B. Imboden. 1992. Association of src-like protein tyrosine kinases with the CD2 cell surface molecule in rat T lymphocytes and natural killer cells. Mol. Cell. Bol. 12:5548-5554.
85. Hatakeyama, M., T. Kono, N. Kobayashi, A. Kawahara, S.D. Levin, R.M. Perlmutter, and T. Taniguchi. 1991. Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association. Science (Wash. DC). 252:1523-1528.
86. Huang, M.M., Z. Indik, L.F. Brass, J.A. Hoxie, A.D. Schreiber, and J.S. Brugge. 1992. Activation of Fc gamma RII induces tyrosine phosphorylation of multiple proteins inducing Fc gamma RII. J. Biol. Chem. 267:5467-5473.
87. Sugie, K., T. Kawakami, M. Y., T. Kawabe, A. Uchida, and J. Yodoi. 1991. Fyn tyrosine kinase associated with Fc epsilon RII/CD23: possible multiple roles in lymphocyte activation. J. Exp. Med. 178:1523-1530.
88. fyn protein tyrosine kinase in T cells. J. Biol. Chem. 267: 12317-12322.
89. Kolanus, W., C. Romeo, and B. Seeds. 1993. T cell activation by clustered tyrosine kinases. Cell. 74:171-183.
90. Liu, Y., and C. Janeway, Jr. 1992. Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells. Proc. Natl. Acad. Sci. USA. 89:3845-3849.
91. Janeway, C.A., and K. Bottomly. 1994. Signals and signs for lymphocyte receptors. Cell. 76:275-285.